HeartGenetics, Genetics & Biotechnology
Latest round
- Seed
Last raised
- Jan 2013
Total raised
- Undisclosed
Investors
- 1
About HeartGenetics, Genetics & Biotechnology
A. operates as a digital health company that develops AI-based tools and wellness genetic tests for creating personalised lifestyle plans for people suffering from cardiovascular diseases and cancer.
Who invested in HeartGenetics, Genetics & Biotechnology
1 investor across 1 round
See all investors in HeartGenetics, Genetics & Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 1, 2013
Amount
Undisclosed
Investors
Questions about HeartGenetics, Genetics & Biotechnology
Who invested in HeartGenetics, Genetics & Biotechnology?
HeartGenetics, Genetics & Biotechnology has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HeartGenetics, Genetics & Biotechnology raised?
HeartGenetics, Genetics & Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did HeartGenetics, Genetics & Biotechnology last raise money?
HeartGenetics, Genetics & Biotechnology's most recent round on record is a Seed, in Jan 2013.
What does HeartGenetics, Genetics & Biotechnology do?
HeartGenetics, Genetics & Biotechnology is a software company.
Where is HeartGenetics, Genetics & Biotechnology headquartered?
HeartGenetics, Genetics & Biotechnology is headquartered in Cantanhede, Portugal.
Which VCs invest in companies like HeartGenetics, Genetics & Biotechnology?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Balderton Capital and Sofinnova Partners back software companies at HeartGenetics, Genetics & Biotechnology's stage. Their profiles are linked below.
VCs backing software startups at Seed
Raising like HeartGenetics, Genetics & Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.